Tuesday, February 9, 2010, 11:16pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

DUSA Pharmaceuticals Inc. (DUSA)

 At 15:54 EST: 1.41 USD  Up 0.05 (3.68%)  
MORE ON DUSA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
DUSA Pharmaceuticals, Inc. (NGM:DUSA) Delayed quote dataEdit
Last Trade: 1.41 USD
Trade Time: 3:54PM EST
Change: Up 0.05 (3.68%)
Prev Close: 1.36
Open: 1.40
Bid: 1.21 x 1500
Ask: 1.49 x 3000
1y Target Est: 6.00
Day's Range: 1.37 - 1.44
52wk Range: 0.88 - 1.87
Volume: 56,060
Avg Vol (3m): 82,360.3
Market Cap: 33.99M
P/E (ttm): N/A
EPS (ttm): -0.20
Div & Yield: N/A (N/A%)
DUSA Pharmaceuticals Inc. (DUSA)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DUSA to Portfolio   Download Data

HEADLINES
• DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
PRNewswire (Tue, Feb 2)
• DUSA PHARMACEUTICALS INC Financials
EDGAR Online Financials (Fri, Nov 13)
• DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• [video] The Pisani Paradox
at TheStreet.com (Mon, Sep 28)
• DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Aug 11)
• DUSA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, May 12)
• DUSA Pharmaceuticals Reports First Quarter 2009 Corporate Highlights and Financial Results
Marketwire (Tue, May 12)
• DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
Marketwire (Mon, May 11)
• DUSA Pharmaceuticals, Inc. Announces First Quarter Financial Results and Corporate Highlights Conference Call
Marketwire (Wed, May 6)
• DUSA Hits the Road With The Skin Cancer Foundation to Raise Awareness of Skin Cancer
Marketwire (Tue, May 5)
More Headlines for DUSA...
ANALYST
EPS Est (next year) (Dec-09) : -0.13
EPS Est (in 2 years) (Dec-10) : 0.03
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
DUSA Pharmaceuticals, Inc., an integrated dermatology pharmaceutical company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices